BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

Clinical trial NCT02137226 · COMPLETED

Trial details

NCT number: NCT02137226
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2015-01-26
Primary completion: 2016-03-03
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.